Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Tristel (TSTL) Share Price

Price 425.00p on 17-08-2026 at 18:05:07
Change 5.00p 1.19%
Buy 430.00p
Sell 420.00p
Last Trade: Buy 110.00 at 425.55p
Day's Volume: 238,507
Last Close: 425.00p
Open: 422.50p
ISIN: GB00B07RVT99
Day's Range 422.50p - 425.00p
52wk Range: 350.00p - 450.00p
Market Capitalisation: £204.10m
VWAP: 423.7958p
Shares in Issue: 48.02m

Tristel (TSTL) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 110 425.55p Ordinary
16:19:10 - 17-Aug-26
Sell* 10,000 424.00p Ordinary
16:17:57 - 17-Aug-26
Buy* 2,298 425.55p Ordinary
16:15:26 - 17-Aug-26
Buy* 1,600 425.55p Ordinary
16:11:03 - 17-Aug-26
Buy* 1,150 425.30p Ordinary
16:09:48 - 17-Aug-26
Sell* 216 420.00p Ordinary
15:50:15 - 17-Aug-26
Buy* 1,000 429.50p Ordinary
15:48:55 - 17-Aug-26
Buy* 500 425.25p Ordinary
15:44:30 - 17-Aug-26
Buy* 461 425.50p Ordinary
15:38:05 - 17-Aug-26
Buy* 2,061 425.20p Ordinary
15:35:30 - 17-Aug-26
See more Tristel trades

Tristel (TSTL) Share Price History

Time period:
to
Date Open High Low Close Volume
14th Aug 2026 (Fri) 421.50 420.00 420.00 420.00 54,557
13th Aug 2026 (Thu) 410.00 410.00 410.00 410.00 38,529
12th Aug 2026 (Wed) 410.00 410.00 410.00 410.00 333,392
11th Aug 2026 (Tue) 407.50 410.00 407.50 410.00 70,016
10th Aug 2026 (Mon) 407.50 410.00 410.00 410.00 24,197
7th Aug 2026 (Fri) 412.50 416.00 410.00 410.00 128,847
6th Aug 2026 (Thu) 415.00 415.00 412.50 412.50 39,136
5th Aug 2026 (Wed) 425.00 420.00 415.00 415.00 78,736
4th Aug 2026 (Tue) 425.00 425.00 425.00 425.00 193,592
3rd Aug 2026 (Mon) 427.50 427.50 425.00 425.00 357,609
31st Jul 2026 (Fri) 427.50 432.50 426.00 426.00 251,859
30th Jul 2026 (Thu) 422.50 430.00 430.00 430.00 186,776
29th Jul 2026 (Wed) 420.00 420.00 420.00 420.00 160,797
28th Jul 2026 (Tue) 410.00 420.00 410.00 420.00 243,214
27th Jul 2026 (Mon) 405.00 412.00 407.50 412.00 139,350
24th Jul 2026 (Fri) 392.50 450.00 450.00 450.00 63,136
23rd Jul 2026 (Thu) 390.00 392.50 390.00 392.50 115,883
22nd Jul 2026 (Wed) 400.00 400.00 380.00 390.00 78,450
21st Jul 2026 (Tue) 380.00 385.00 380.00 385.00 58,917
20th Jul 2026 (Mon) 380.00 380.00 380.00 380.00 101,159
17th Jul 2026 (Fri) 380.00 380.00 380.00 380.00 39,605
See more Tristel price history

Tristel (TSTL) Regulatory News

Date Source Headline
11th Aug 2026 2:55 pm RNS Exercise of Share Options and Total Voting Rights
31st Jul 2026 10:05 am RNS Exercise of Share Options and Total Voting Rights
27th Jul 2026 7:00 am RNS-R 3T Pro commercial launch
22nd Jul 2026 7:00 am RNS Positive Trading Update
7th Jul 2026 3:04 pm RNS Holding(s) in Company
7th Jul 2026 7:00 am RNS-R APIC26 Annual Conference attendance
17th Jun 2026 7:00 am RNS Appointment of CEO
16th Jun 2026 12:00 pm RNS Holding(s) in Company
10th Jun 2026 7:00 am RNS Exercise of Share Options & Total Voting Rights
13th May 2026 10:10 am RNS Exercise of Share Options and Total Voting Rights
See more Tristel regulatory news

Tristel (TSTL) Share News

TRADING UPDATES: Canal+ signs EUR980 million French cinema deal

27th Jul 2026 19:52

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

WINNERS & LOSERS: Pinewood and Pharos back takeover offers

27th Jul 2026 10:23

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. Read More

IN BRIEF: Tristel names Christopher Lee as next chief executive

17th Jun 2026 15:40

Tristel PLC - Newmarket, England-based maker of infection prevention products - Appoints Christopher Lee as chief executive officer with effect from August 1, succeeding Matt Sassone, who is leaving on June 30. Names Chief Financial Officer Anna Wasyl to serve as interim CEO before Lee assumes the role. Says Sassone is moving to "a worldwide president role with a large US multinational." Lee was CEO of medical device company Summit Medical Ltd from 2020 to 2025. He is currently non-executive chair of Venner Medical Deutschland GmbH, having served as respiratory and anaesthesia products company Venner Medical International's CEO from 2013 to 2020, and worked at Johnson & Johnson for 18 years. Company says that at Summit he led its strategic development and growth, overseeing multiple subsidiaries and driving international expansion, and that overall he has more than 35 years' experience in the medical technology and healthcare industry. Read More

LONDON BROKER RATINGS: UBS raises BP; Berenberg cuts Antofagasta

16th Apr 2026 09:55

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More

UK dividends calendar - next 7 days

2nd Apr 2026 12:07

Read More

See more Tristel news
FTSE 100 Latest
Value10,720.30
Change-29.81

Login to your account

Forgot Password?

Not Registered